Echt, Netherlands

Ben De Lange

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Munstergeleen, NL (2010 - 2013)
  • Echt, NL (2014 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ben De Lange

Introduction

Ben De Lange is a notable inventor based in Echt, Netherlands, recognized for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, he has made remarkable advancements in the development of various chemical processes.

Latest Patents

Among his latest patents is a method for acylating a cyclic peptide. This invention relates to a process for acylating cyclic peptides bearing an amino group and highlights its application in the preparation of anidulafungin and micafungin. Another significant patent is a process for preparing a statin precursor. This process involves multiple reaction steps, including the reaction of a hydroxy-pyrimidine-carbonitrile with an organic sulfonyl halide to form a sulfonate-pyrimidine-carbonitrile, followed by further reactions to produce a pyrimidinyl-sulfonamide, all conducted in toluene as the main solvent.

Career Highlights

Ben De Lange has worked with prominent companies such as Dsm Sinochem Pharmaceuticals Netherlands B.V. and Dsm IP Assets B.V. His work in these organizations has contributed to the advancement of pharmaceutical innovations and the development of new chemical processes.

Collaborations

Throughout his career, Ben has collaborated with notable colleagues, including Dennis Heemskerk and Karin Henderika Maria Bessembinder. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Ben De Lange's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His innovative methods continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…